Results 161 to 170 of about 29,053 (244)

Tumor microenvironment-responsive precise delivery nanocarrier potentiating synchronous radionuclide therapy and chemotherapy against cancer. [PDF]

J Nanobiotechnology
An J, Zhou Q, Chu K, Chen S, Niu C, Zhang W, Gao J, Li M, Cao J, Lv J, Zhang D, Wu Z, Li S, Wei H.   +13 more
europepmc   +1 more source

[131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma

, 2011
Stefanie Hahner, Michael C. Kreißl, Martin Faßnacht, Heribert Haenscheid, Pascal Knoedler, Katharina Lang, Andreas K. Buck, Christoph Reiners, Bruno Allolio, Andreas Schirbel   +9 more
openalex   +1 more source

Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy [PDF]

, 2016
Claire Viallard, Jean‐Michel Chezal, Florence Mishellany, Isabelle Ranchon-Cole, Bruno Pereira, Aurélie Herbette, Sophie Besse, Zied Boudhraa, Nathalie Jacquemot, Anne Cayre, Elisabeth Miot-Noirault, Jian‐Sheng Sun, Marie Dutreix, Françoise Degoul   +13 more
openalex   +1 more source

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Stemann Lau T, Bossen L, Rasmussen DGK, Genovese F, Karsdal M, Arveschoug AK, Grønbæk H, Dam G.   +7 more
europepmc   +1 more source

Selective intraarterial radionuclide therapy with yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: Initial experience at a single center

, 2011
Nuri Arslan, Mustafa Emi, Engin Alagöz, Bahri Üstünsöz, Kaan Oysul, Fikret Arpacı, Şahin Uğurel, Murat Beyzadeoğlu, Ali Aykan Özgüven   +8 more
openalex   +2 more sources

Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy. [PDF]

Front Oncol
Cengiz TB, Kulkarni R, Corbett V, Ghesani NV, Wolin E, Ghesani MV.   +5 more
europepmc   +1 more source

Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment [PDF]

, 2017
Hossein Jadvar
openalex   +1 more source

Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Mathew A, Kersting D, Fendler WP, Braegelmann J, Fuhrer D, Lahner H.   +5 more
europepmc   +1 more source

Direct Labeling of Gold Nanoparticles with Iodine-131 for Tumor Radionuclide Therapy. [PDF]

Int J Nanomedicine
Zhu M, Zhao L, Lu X.
europepmc   +1 more source

An ACTH-Producing Neuroendocrine Tumor: Clinical Course of Multidisciplinary Therapy Including Peptide Receptor Radionuclide Therapy - A Case Report. [PDF]

Case Rep Oncol
Koizumi T, Sato A, Kitajima K, Yamazaki M, Kanazawa S, Notake T, Sato Y, Kobayashi S, Iwaya M, Umeda T, Komatsu M.   +10 more
europepmc   +1 more source